[HTML][HTML] Epidemiology of bladder cancer in 2023: a systematic review of risk factors
Context Bladder cancer (BC) is common worldwide and poses a significant public health
challenge. External risk factors and the wider exposome (totality of exposure from external …
challenge. External risk factors and the wider exposome (totality of exposure from external …
Advances in bladder cancer biology and therapy
The field of research in bladder cancer has seen significant advances in recent years. Next-
generation sequencing has identified the genes most mutated in bladder cancer. This …
generation sequencing has identified the genes most mutated in bladder cancer. This …
Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
T Powles, J Bellmunt, E Comperat… - Annals of …, 2022 - annalsofoncology.org
Urothelial carcinoma (UC), also described as bladder cancer, is the 10th most common
cancer type worldwide, with an estimated 549 000 new cases and 200 000 deaths in 2018 …
cancer type worldwide, with an estimated 549 000 new cases and 200 000 deaths in 2018 …
Epidemiology of bladder cancer
Based on the latest GLOBOCAN data, bladder cancer accounts for 3% of global cancer
diagnoses and is especially prevalent in the developed world. In the United States, bladder …
diagnoses and is especially prevalent in the developed world. In the United States, bladder …
[HTML][HTML] Role of FGFR3 in bladder cancer: Treatment landscape and future challenges
CM Ascione, F Napolitano, D Esposito… - Cancer Treatment …, 2023 - Elsevier
Bladder cancer is a heterogeneous malignancy and is responsible for approximately 3.2%
of new diagnoses of cancer per year (Sung et al., 2021). Fibroblast Growth Factor Receptors …
of new diagnoses of cancer per year (Sung et al., 2021). Fibroblast Growth Factor Receptors …
Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018
Context Bladder cancer (BC) is a significant health problem, and understanding the risk
factors for this disease could improve prevention and early detection. Objective To provide a …
factors for this disease could improve prevention and early detection. Objective To provide a …
European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)-2019 update
M Babjuk, M Burger, EM Compérat, P Gontero… - European urology, 2019 - Elsevier
Context This overview presents the updated European Association of Urology (EAU)
guidelines for non–muscle-invasive bladder cancer (NMIBC), TaT1, and carcinoma in situ …
guidelines for non–muscle-invasive bladder cancer (NMIBC), TaT1, and carcinoma in situ …
Recurrence mechanisms of non-muscle-invasive bladder cancer—A clinical perspective
Non-muscle-invasive bladder cancer (NMIBC) is an early-stage cancer without invasion into
the detrusor muscle layer. Transurethral resection of bladder tumour (TURBT) is a diagnostic …
the detrusor muscle layer. Transurethral resection of bladder tumour (TURBT) is a diagnostic …
Bladder cancer incidence and mortality: a global overview and recent trends
S Antoni, J Ferlay, I Soerjomataram, A Znaor, A Jemal… - European urology, 2017 - Elsevier
Context Bladder cancer has become a common cancer globally, with an estimated 430 000
new cases diagnosed in 2012. Objective We examine the most recent global bladder cancer …
new cases diagnosed in 2012. Objective We examine the most recent global bladder cancer …
Bladder cancer
O Sanli, J Dobruch, MA Knowles, M Burger… - Nature reviews Disease …, 2017 - nature.com
Bladder cancer is a highly prevalent disease and is associated with substantial morbidity,
mortality and cost. Environmental or occupational exposures to carcinogens, especially …
mortality and cost. Environmental or occupational exposures to carcinogens, especially …